Talkspace, Inc. (TALK)
USD 3.09
(-5.21%)
USD 3.09
(-5.21%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 142.22 Million USD | -8.98% |
| 2022 | 156.25 Million USD | -30.12% |
| 2021 | 223.6 Million USD | 580.21% |
| 2020 | 32.87 Million USD | -21.6% |
| 2019 | 41.92 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 138.27 Million USD | -2.77% |
| 2024 Q2 | 133.78 Million USD | -3.24% |
| 2024 Q3 | 138.23 Million USD | 3.32% |
| 2023 Q2 | 140.52 Million USD | -2.94% |
| 2023 Q3 | 140.34 Million USD | -0.12% |
| 2023 Q4 | 142.22 Million USD | 1.33% |
| 2023 Q1 | 144.78 Million USD | -7.34% |
| 2023 FY | 142.22 Million USD | -8.98% |
| 2022 Q2 | 187.46 Million USD | -8.74% |
| 2022 FY | 156.25 Million USD | -30.12% |
| 2022 Q4 | 156.25 Million USD | -11.03% |
| 2022 Q3 | 175.63 Million USD | -6.31% |
| 2022 Q1 | 205.41 Million USD | -8.14% |
| 2021 FY | 223.6 Million USD | 580.21% |
| 2021 Q1 | 414.8 Million USD | 1161.84% |
| 2021 Q2 | 270.2 Million USD | -34.86% |
| 2021 Q3 | 248.95 Million USD | -7.86% |
| 2021 Q4 | 223.6 Million USD | -10.18% |
| 2020 Q2 | 27.56 Thousand USD | -8.12% |
| 2020 Q1 | 30 Thousand USD | 0.0% |
| 2020 FY | 32.87 Million USD | -21.6% |
| 2020 Q4 | 32.87 Million USD | -92.06% |
| 2020 Q3 | 414.14 Million USD | 1502456.62% |
| 2019 FY | 41.92 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 97.346% |
| Addus HomeCare Corporation | 1.02 Billion USD | 86.117% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | 33.402% |
| Amedisys, Inc. | 2.06 Billion USD | 93.097% |
| American Oncology Network, Inc. | 374.45 Million USD | 62.019% |
| Astrana Health, Inc. | 933.36 Million USD | 84.762% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 91.313% |
| IMAC Holdings, Inc. | 1.14 Million USD | -12330.613% |
| biote Corp. | 155.29 Million USD | 8.419% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -132.308% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 79.064% |
| COMPASS Pathways plc | 275.98 Million USD | 48.468% |
| DocGo Inc. | 490.45 Million USD | 71.002% |
| The Ensign Group, Inc. | 4.17 Billion USD | 96.596% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 82.293% |
| InnovAge Holding Corp. | 547.66 Million USD | 74.031% |
| Assure Holdings Corp. | 7.51 Million USD | -1792.747% |
| The Joint Corp. | 87.15 Million USD | -63.189% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 93.632% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -1688.805% |
| ModivCare Inc. | 1.76 Billion USD | 91.953% |
| NewGenIvf Group Limited | 1.64 Million USD | -8532.744% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -299.912% |
| Option Care Health, Inc. | 3.32 Billion USD | 95.727% |
| P3 Health Partners Inc. | 860.96 Million USD | 83.481% |
| P3 Health Partners Inc. | 860.96 Million USD | 83.481% |
| The Pennant Group, Inc. | 539.69 Million USD | 73.648% |
| Surgery Partners, Inc. | 7.01 Billion USD | 97.974% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -2788.743% |
| Talkspace, Inc. | 142.22 Million USD | 0.0% |
| The Oncology Institute, Inc. | 219.41 Million USD | 35.183% |
| The Oncology Institute, Inc. | 219.41 Million USD | 35.183% |